A GLOBAL LEADER

IN PERSONALIZED
NUTRITION
Forward Looking Statements
Management will make forward-looking
statements during this presentation.
Actual results could differ from those projected
in such forward-looking statements, which
involve a number of risks and uncertainties and
should be considered in conjunction with the
cautionary statements contained in our most
recent filings with the SEC.
is a direct selling company that

PERSONALIZES
Creating the Healthiest Family on Earth

2017 STRONG Personalized 586K

25 th and STABLE PRODUCT ACTIVE
ANNIVERSARY Balance STRATEGY CUSTOMERS
Sheet and 24
COUNTRIES
WORLDWIDE TRENDS
INDICATE GREATER CONSUMER NEED

INCREASING HEALTH INCREASING FITNESS &

AWARENESS HEALTH FOCUS

AGING RISING GROWING

POPULATION HEALTHCARE COSTS OBESITY
ADVANTAGES

HEALTH BUSINESS
BEST-IN-CLASS ENTREPRENEURIAL
PRODUCTS PROMOTE OPPORTUNITIES FOR
LONG-TERM BENEFITS FINANCIAL FREEDOM
ADVANTAGES
DIFFERENTIATED EFFECTIVENESS
PRODUCT HIGHEST BACKED BY
STRATEGY QUALITY SCIENCE

WORLD-CLASS MARKETING TOP-RATED

ATHLETE PARTNERSHIPS PRODUCTS AND
SPONSORSHIPS COMPANY
DIFFERENTIATED
PRODUCT STRATEGY

NUTRITIONALS FOODS SKIN CARE

% % %
Percent of Net Sales for 2018
EFFECTIVENESS BACKED BY

SCIENCE
Over 60 SCIENTISTS
On Staff

ON-SITE R&D
Laboratories and Facilities

PRODUCTS & INGREDIENTS

Ongoing Internal and External Studies
EFFECTIVENESS BACKED BY

SCIENCE Clinical Levels of Nutrients

100%

RDA
75% Diet
Typical Vitamin
USANA

50%

25%

0%
VITAMIN E VITAMIN D FOLIC ACID
 Blood
Vitamin C CONCENTRATION
Health Benefit Enzyme / Function / Mechanism

Cardiovascular Antioxidant Activity

Health eNOS/BH4
Concentration

Lack of Energy Carnitine and Catecholamine

Fatigue Synthesis

RDA
Malnutrition Collagen Synthesis

Dose (mg/day)

Ames, B. “The Triage Theory”

 OF HUMAN
NUTRITION
1. Essential vitamins & minerals
2. Antioxidant protection
3. Additional nutritional
4. Incelligence technology
 CELLULAR
Types of Inputs Inputs SURVEILLANCE
• Toxins
• Stress Protein A

Protein B
Nutrients
ANTI-STRESS
TURN ON Protein C
PROTEINS
genes Nucleus
Protein C
Anti-stress genes
11
The Difference
MATERIALS
FORMULAS
MANUFACTURING
INNOVATION
MONITORING
HIGHEST QUALITY

TWO-THIRDS OF ALL PRODUCTS

manufactured In-house

REGISTERED with numerous government

agencies including the FDA

VOLUNTARILY in compliance with more

demanding drug-model GMPs
OFFICIAL
HEALTH
SUPPLEMENT
SUPPLIER
Over 1,000+ World-Class
athletes TRUST THEIR
PERFORMANCE TO
 PARTNERSHIPS

is the TRUSTED PARTNER and SPONSOR

®

of The Dr. Oz Show

ESTABLISHED

MARKET PRESENCE

20TH LARGEST
DIRECT SELLING COMPANY OPERATIONS IN 24
IN THE WORLD COUNTRIES
GLOBAL

PRESENCE
GREATER
CHINA
AMERICAS &
EUROPE
NORTH
ASIA

SOUTHEAST
ASIA

TTM - Q1 2019
REGIONAL

SALES HISTORY
($000’s USD) $700,000

$600,000

Americas and Europe

$500,000
Southeast Asia/Pacific
Greater China
$400,000 North Asia

$300,000

$200,000

$100,000

$0
FY2013 FY2018
CONTINUED

MARKET EXPANSION
Top 20 Direct Selling Markets

1. United 6. Brazil 11. Taiwan 16. Canada

States
7. Mexico 12. Italy 17. Argentina
2. China
8. Malaysia 13. Thailand 18. Peru
3. Korea
9. France 14. Colombia 19. Philippines
4. Germany
10. United 15. Russia 20. Australia
5. Japan Kingdom
Existing Markets Potential Markets Opened Q2 2018

Source: Direct Selling Association

DISTRIBUTION

NETWORK
15%
Sold via independent Full-Time

Associates
Majority work Part-Time
Pay based on
Performance
85 %
Part-Time
DIRECT SELLING
*Source: Direct Selling Association
A LONG-STANDING PROGRAM

PREFERRED CUSTOMERS

291,000 60%
of total active customers in the United States
TOTAL ACTIVE are
PREFERRED PREFERRED
CUSTOMERS
CUSTOMERS

Q1 2019
COMPENSATION PLAN
RETAIL SALES
WEEKLY COMMISSIONS
LIFETIME MATCHING BONUS
ELITE BONUS
INCENTIVE PROGRAMS
LEADERSHIP BONUS
PERSONALIZATION
DRIVES FUTURE GROWTH

It’s
about
YOU
HEALTH
Trusted nutritional supplements
BUSINESS
Flexible with time and need
Personally-designed systems Wide range of tools and
Diverse products that meet a technology to build and sustain
great number of needs Incentives drive performance
at multiple levels
PERSONALIZATION
A FUTURE OF CUSTOMIZED SOLUTIONS
Proprietary blend of 8 NUTRIENTS that activate
your cells’ natural ability to protect and renew
themselves – cell signaling
THREE PROVISIONAL PATENTS on file with the U.S. PTO
OPERATIONAL

EFFICIENCY

IN-HOUSE CENTRALIZED SCIENTIFIC

MANUFACTURING I.T. EXPERTISE
OPERATIONAL

EFFICIENCY & CONTROLS

MANAGE cost structure
Better CONTROL of inventory levels
SCHEDULING control ensures
effective resource turnaround
LEVERAGE opportunities from
investment in production facilities
CENTRALIZED IT and common systems
STRATEGIC INITIATIVES
CELAVIVE
USANA’s all-new skincare line – staggered launches throughout FY18

RESEARCH & DEVELOPMENT

Continued product and technology growth

IT INVESTMENTS
Continued investment in information technology, infrastructure and operations

SOCIAL SHARING
NEW EUROPEAN
Germany, Italy, Romania, Spain
MARKETS
COMPANY PERFORMANCE
SALES & CUSTOMER GROWTH
650,000
$1,200

600,000
$1,100

550,000
$1,000

500,000
$900
Total Customers Net Sales $ millions
450,000
$800

400,000
$700

350,000 10-Year CAGR $600

Net Sales Customers
300,000
10.7% 8.6% $500

250,000 $400

200,000 $300

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
STRONG

FINANCIAL PERFORMANCE
(In millions, except for per share data) FY2017 FY2018 TTM 2019

Net Sales $1,047 $1,189 $1,170

Operating Margin 12.7% 15.8% 15.4%

EPS - Diluted $2.53 $5.12 $5.08

Shares - Diluted 24.7 24.6 23.9

EBITDA $149 $205 $196

2019 Q1

FINANCIALS
(In millions, except for per share data) Q1 2018 Q1 2019

Net Sales $292 $273

Operating Margin 14.8% 12.8%
EPS - Diluted $1.19 $1.01
Shares - Diluted 24.3 23.9
EBITDA $48 $39
 *TTM - Q1 2019

STRONG AND STABLE

BALANCE SHEET FY2017 FY2018 Q1 2019

(In millions, except for per share data)
Cash $247 $214 $225
Total Debt $0 $0 $0
Cap Ex* $13 $11 $11
Free Cash Flow* $111 $141 $127
Cash per Diluted Share $10.00 $8.70 $9.41
Share Repurchases* $50 $105 $132

 Vertical Integration  Investments in China

Current and Potential  Share Repurchase  Targeted Acquisitions
Uses of Cash  Investments in Technology  International Expansion
 New Product Development
OUTLOOK 2019
LOW HIGH

$1.21B $1.26B NET

SALES

$5.00 $5.35 EPS

The
PERSONALIZED
nutrition company